Yi Q, Han X, Yu HG, Chen HY, et al. SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain. Oncogene 2024 Mar 26. doi: 10.1038/s41388-024-02944.
PMID: 38532114